TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$1.24
+0.01 (+0.81%)
As of Sep 29, 10:19 PM ET ·
Financial Highlights (FY 2026)
Revenue
74.82M
Net Income
-36,189,248
Gross Margin
67.7%
Profit Margin
-48.4%
Rev Growth
+24.7%
D/E Ratio
8.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 74.82M 60.01M 7.47M 7.60M
Gross Profit 50.64M 40.62M 2.11M 2.15M
Operating Income -32,290,419 -23,308,772 1.36M 1.26M
Net Income -36,189,248 -26,123,133 1.27M 1.28M
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Rev Growth +24.7% +24.7% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.54M 25.54M 9.64M 8.55M
Total Equity 2.90M 2.90M 26.51M 24.38M
D/E Ratio 8.82 8.82 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,700,048 -24,153,870 2.01M 2.00M
Free Cash Flow — — 1.14M 1.46M